NASDAQ
BioInvent International AB (publ) (BOVNF) has a price/fcf ratio of -7.84x as of Tuesday, May 26, 2026. This represents a 63.59% increase compared to its 12-month average of -21.54x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.